Product Program year 2025 Source: CMS Open Payments

Amplatzer

Device Structural Heart

PDI 00811806011301

Open in the dashboard

General payments

$135,740

642 payments

Research payments

$158,709

81 payments

Through program year 2025, $135,740 in general payments and $158,709 in research payments were reported against Amplatzer (Structural Heart).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $45,304 361
2024 General $40,533 137
2024 Research $92,217 36
2023 General $49,904 144
2022 Research $66,492 45

Breakdown

Who paid General payments · program years 2023–2025
  1. Abbott Laboratories $135,740 642 payments
Top recipients General payments · program year 2025
  1. Anthony Ea Cardiovascular Disease · Mountain View, CA $6,213 14% · 3 payments
  2. Jay Traverse Interventional Cardiology · Minneapolis, MN $4,100 9% · 4 payments
  3. Ehete Bahiru Cardiovascular Disease · Rancho Mirage, CA $2,431 5% · 8 payments
  4. Steven Roh Interventional Cardiology · Minneapolis, MN $2,200 5% · 3 payments
  5. James Lee Cardiovascular Disease · Detroit, MI $1,277 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $16,908 37% · 57 practitioners
  2. Cardiovascular Disease Internal Medicine $15,285 34% · 22 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $7,436 16% · 32 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $1,390 3% · 2 practitioners
  5. Nurse Anesthetist, Certified Registered $1,030 2% · 1 practitioner

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $15,502 34% · 27 recipients
  2. Minnesota $6,611 15% · 5 recipients
  3. New York $2,972 7% · 8 recipients
  4. Texas $2,683 6% · 17 recipients
  5. Florida $2,478 5% · 15 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

642 general · 81 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record